The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen � Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja � CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection.
Through its participation in this year�s ISER meeting Experimentica Ltd. is proud to be able to showcase its scientific know-how as well as its world-class researchers through its presentations and abstracts. It is our hope that attendees will feel free to make contact with them in order to discuss their scientific research as well as the Experimentica Ltd. product offering.
Experimentica Ltd. extends a warm welcome to all attendees at this years meeting.
The times of the presentation and sessions are below:
Dr. Jenni J. Hakkarainen, Finland
Protection by a Metalloporphyrin Superoxide Dismutase Mimetic against Signs of Dry-eye Disease
Dry eye disease, Meeting Room 3B, 13.09.2018 16:54-17:06
Dr. Simon Kaja, USA
Cellular Mechanisms of Reactive Astrocytosis and Opportunities for Glioprotection
Ocular Pharmacology, Therapeutics and Drug Discovery, Meeting Room 3A 13.09.2018 13:00-15:00.
About Experimentica Ltd.: Experimentica Ltd. is a global contract research organization (CRO) that specializes in preclinical models of ophthalmology and neurology. The world class scientists and technicians apply a comprehensive set of skills on various in vitro, ex vivo and in vivo modelling platforms. With proprietal laboratories in Kuopio, Finland, and representation globally, Experimentica Ltd. delivers the highest quality science in ophthalmology and neurological models.